This might be the first post ever here for GID as far as I know. Management have laid the story on the line. The first trials of their new endio barrier device were abandoned due to patient discomfort. After a further period of research, the device has been readied for another series of patient trials. As such, GID is funded to take these trials through to fruition. The share price lifted today, and then I bought a few, but I wasn't the only one as the no. sales show me. Seems there are other high risk punter/s idiots willing to give this obscure little company a shot.
GID Price at posting:
2.1¢ Sentiment: Hold Disclosure: Held
